On Friday, the House Appropriations Committee approved a bill that would prevent "spread pricing" and increase regulations on PBMs, two days after the Senate unanimously passed its version.
The lawsuit briefly described steps Florida has taken to carry out the program but said it remains "stuck in the starting blocks" while waiting for an FDA decision.